Skip to content

Member

Giorgos GEORGIOU

The Left · Cyprus

Group
The Left
Country
Cyprus
Roll-call participation
78.4 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
81.3 %ⓘ of 482 votes where the group had a line · The Left median 86.6 %
More facts (5)
National party
AKEL-ARISTERA-ND Progressive Party of Working People - Left - New Forces
In office
Since 16 Jul 2024
Against clear line
49 of 406 votesⓘ
Committees
AFET, ENVI (substitute), SANT (substitute)
Member id
197416
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

78.4 %

486 of 620 final votes while in office

The Left median: 86.9 % (−8.5 pts)

Chamber median: 90.6 %

With majority line ⓘ

81.3 %

392 of 482 votes where their group had a line

The Left median: 86.6 % (−5.3 pts)

Against clear line ⓘ

12.1 %

49 of 406 votes where their group had a clear line

3 opposite (for ↔ against), 42 abstained against the line, 4 voted for or against when the line was to abstain

Abstention ⓘ

19.5 %

95 of 486 votes cast

Participation 78.4 % — The Left median 86.9 %, 47 members.ⓘ
Data as a table
Participation among the 47 members of the The Left with enough votes.
FigureParticipation
Giorgos GEORGIOU78.4 %
The Left median86.9 %
Lowest in the group37.7 %
Highest in the group99.4 %
Members47
With majority line 81.3 % — The Left median 86.6 %, 47 members.ⓘ
Data as a table
With majority line among the 47 members of the The Left with enough votes.
FigureWith majority line
Giorgos GEORGIOU81.3 %
The Left median86.6 %
Lowest in the group64.5 %
Highest in the group91.8 %
Members47
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of The Left; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: Abstained Majority line: Abstained
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: Abstained Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: Against Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: No vote recorded Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 18 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within The Left

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Martin GÜNTHER The LeftGermany93 % of 2 229 shared87 %
Özlem DEMIREL The LeftGermany93 % of 4 103 shared87 %
Rudi KENNES The LeftBelgium93 % of 4 470 shared87 %
Marc BOTENGA The LeftBelgium92 % of 3 987 shared87 %
Irene MONTERO The LeftSpain91 % of 4 155 shared87 %
Catarina MARTINS The LeftPortugal90 % of 3 625 shared87 %
Isabel SERRA SÁNCHEZ The LeftSpain90 % of 2 640 shared87 %
Luke Ming FLANAGAN The LeftIreland90 % of 3 510 shared87 %
Martin SCHIRDEWAN The LeftGermany90 % of 4 206 shared87 %
Estrella GALÁN The LeftSpain90 % of 3 903 shared87 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Ana MIRANDA PAZ GreensSpain81 % of 3 583 shared77 %
Vicent MARZÀ IBÁÑEZ GreensSpain80 % of 4 124 shared77 %
Maria ZACHARIA No groupGreece79 % of 4 470 shared37 %
Cristina GUARDA GreensItaly79 % of 3 959 shared77 %
Benedetta SCUDERI GreensItaly79 % of 4 307 shared77 %
Jaume ASENS LLODRÀ GreensSpain78 % of 3 694 shared77 %
Leoluca ORLANDO GreensItaly78 % of 4 059 shared77 %
David CORMAND GreensFrance78 % of 4 417 shared77 %
Diana RIBA I GINER GreensSpain77 % of 3 989 shared77 %
Mélissa CAMARA GreensFrance77 % of 3 902 shared77 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation to the EU-Türkiye Joint Parliamentary CommitteeD-TR Joint parliamentary committeeMember19 Sept 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember24 Jan 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeSubstitute19 Jul 202419 Jan 2025

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Modernised rules for patients’ rights in cross-border healthcareRapporteurSANT24 Apr 2026
A new co-ownership for the future of Euro-Mediterranean relations – the Pact for the MediterraneanShadow rapporteurAFET24 Apr 2026
EU rare disease action planShadow rapporteurSANT5 Mar 2026
COSAC mission to Cyprus, 15-17 March Official delegation24 Feb 2026
Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034Shadow rapporteur for an opinionENVI30 Jan 2026
No dossier namedShadow rapporteurAFET13 Jan 2026
2025 Commission report on MontenegroShadow rapporteurAFET13 Jan 2026
2025 Commission report on Bosnia and HerzegovinaShadow rapporteurAFET13 Jan 2026
Enhanced Partnership and Cooperation Agreement between the European Union, of the one part, and the Republic of Uzbekistan, of the other partShadow rapporteurAFET13 Jan 2026
Committee on Women's Rights and Gender Equality - Mission to Nicosia, Cyprus 26-28 May 2025Official delegation21 May 2025

Show all 25 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

46 contributions recorded; 24 on behalf of their group; 64 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
15 Sept 2026Escalation in the Middle East (debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
7 Jul 2026The impact of the 1974 Turkish invasion on Cypriot women and girls, and the crimes committed by Turkish forces and consequences on gender equality (debate) on behalf of The LeftSpeech · 1 minRead
6 Jul 2026One-minute speeches on matters of political importance Speech · 1 minRead
16 Jun 20262025 Commission report on Türkiye (debate) on behalf of The LeftSpeech · 2 minRead
29 Apr 2026Situation in Lebanon: implementation of the ceasefire, support peace efforts and humanitarian access (debate) on behalf of The LeftSpeech · 1 minRead
28 Apr 2026Supporting democratic resilience in Armenia (debate) on behalf of The LeftSpeech · 1 minRead
28 Apr 2026The Commission’s 2025 Rule of Law report (debate) on behalf of The LeftSpeech · 1 minRead
11 Mar 2026EUCO and situation in the Middle East (joint debate) Speech · 1 minRead
10 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire (debate) Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 81

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
15 Sept 2026Common security and defence policy mission to Lebanon E-10-2026-003673Written questionwith 11 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
25 Jun 2026The recent coercive measures imposed by the United States against Cuba, their extraterritorial nature and the measures to be adopted to defend the interests of individuals and companies from EU countries O-10-2026-000029Oral questionwith 27 co-authorsNot yet answered
24 Jun 2026Opening of AKP representative office in occupied Nicosia, in a historic building that is purportedly a cultural heritage monument E-10-2026-002588Written questionNot yet answered
24 Jun 2026ECB’s decision to raise interest rates and its impact on the rising cost of living O-10-2026-000028Oral questionwith 39 co-authorsNot yet answered
17 Jun 2026Circumvention of the EU-Israel Association Agreement and illegal imports from settlements in the occupied territories E-10-2026-002521Written questionwith 13 co-authors18 Sept 2026
12 Jun 2026MOTION FOR A RESOLUTION on the political repression and humanitarian situation in Cuba B-10-2026-0289Motion for a resolutionwith 29 co-authors—
19 May 2026Legislation on borrowers’ rights referred back to legislature E-10-2026-002057Written questionNot yet answered
19 May 2026MOTION FOR A RESOLUTION on holding Israel to account for breaches of human rights and international law B-10-2026-0267Motion for a resolutionwith 55 co-authors—
24 Apr 2026MOTION FOR A RESOLUTION on supporting democratic resilience in Armenia B-10-2026-0197Motion for a resolutionwith 1 co-author—

Show all 81 questions and motions

Amendments tabled in committee, 41

Committee amendment documents that carry amendments by the member, with how many are theirs.

Show all 41 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political groups this term

National delegation

  • Delegation Cyprus National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
2 October 2026

Cite as

EU Parl Watch Research (2026). “Giorgos GEORGIOU”. Member record. memberId 197416. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197416?page=77&scope=final&vscope=all (retrieved 2 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197416. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197416?format=application%2Fld%2Bjson (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197416,
  author = {{EU Parl Watch Research}},
  title = {{Giorgos GEORGIOU}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197416?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197416?page=77&scope=final&vscope=all},
  urldate = {2026-10-02},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197416. Official source: https://www.europarl.europa.eu/meps/en/197416. Data: EP Open Data: member record (CC BY 4.0); data version 343d33dd3e67 (2 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}